Related references
Note: Only part of the references are listed.Pseudomonas aeruginosa in chronic obstructive pulmonary disease
Timothy F. Murphy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Macrolides as immunomodulatory medications for the therapy of chronic lung diseases
Yolanda S. Lopez-Boado et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Targeting tight junction proteins-significance for drug development
Masuo Kondoh et al.
DRUG DISCOVERY TODAY (2008)
Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators
Evangelos J. Giamarellos-Bourboulis
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
P. Meers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function
Grace Soong et al.
JOURNAL OF BACTERIOLOGY (2008)
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P-aeruginosa lung infection in Cftr-/- mice
Nadine Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Differentiation potential of a basal epithelial cell line established from human bronchial explant
Skarphedinn Halldorsson et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2007)
Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection
Joanna Rejman et al.
HUMAN GENE THERAPY (2007)
New diseases derived or associated with the tight junction
Marcelino Cereijido et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Tight junction modulation and biochemical characterisation of the zonula occludens toxin C- and N-termini
E. Schmidt et al.
FEBS LETTERS (2007)
Opportunistic infections in lung disease:: Pseudomonas infections in cystic fibrosis
Marisa I. Gomez et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Paracellular permeability restricts airway epithelial responses to selevtively allow activation by mediators at the basolateral surface
Alicia L. Humlicek et al.
JOURNAL OF IMMUNOLOGY (2007)
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells
Cristina Cigana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pseudomonas aeruginosa quorum sensing molecule N-(3 oxododecanoyl)-L-homoserine lactone disrupts epithelial barrier integrity of Caco-2 cells
Elena Vikstrom et al.
FEBS LETTERS (2006)
Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells
Cristina Cigana et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Diffuse panbronchiolitis
V. Poletti et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial
A. Clement et al.
THORAX (2006)
Epithelial paracellular proteins in health and disease
Daniel Landau
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa
L Zulianello et al.
INFECTION AND IMMUNITY (2006)
Novel effects of azithromycin on tight junction proteins in human airway epithelia
V Asgrimsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Production of rhamnolipids by Pseudomonas aeruginosa
G Soberón-Chávez et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
R Bals et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis
MJ Schultz
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Azithromycin retards Pseudomonas aeruginosa Biofilm Formation
RJ Gillis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Foxj1 is required for apical localization of ezrin in airway epithelial cells
T Huang et al.
JOURNAL OF CELL SCIENCE (2003)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor
PD Vermeer et al.
NATURE (2003)
P-aeruginosa quorum-sensing systems and virulence
RS Smith et al.
CURRENT OPINION IN MICROBIOLOGY (2003)
Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis
DL Erickson et al.
INFECTION AND IMMUNITY (2002)
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa
K Tateda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry:: application ito a model bacterial biofilm
TS Charlton et al.
ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
